CYB5RL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.089600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.230000E-01
Normal-vs-Stage2
4.597700E-02
Normal-vs-Stage3
1.893180E-01
Normal-vs-Stage4
4.942600E-01
Stage1-vs-Stage2
4.287400E-01
Stage1-vs-Stage3
2.214200E-02
Stage1-vs-Stage4
6.764400E-01
Stage2-vs-Stage3
4.11850000000547E-05
Stage2-vs-Stage4
2.952400E-01
Stage3-vs-Stage4
3.963300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.265600E-02
Normal-vs-AfricanAmerican
3.534600E-01
Normal-vs-Asian
5.710400E-02
Caucasian-vs-AfricanAmerican
6.575600E-01
Caucasian-vs-Asian
3.900600E-01
AfricanAmerican-vs-Asian
4.045800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.621700E-02
Normal-vs-Female
8.332000E-02
Male-vs-Female
2.584800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.245800E-01
Normal-vs-Age(41-60Yrs)
6.311700E-02
Normal-vs-Age(61-80Yrs)
5.023900E-02
Normal-vs-Age(81-100Yrs)
4.463500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.855400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.872000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.119800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.341200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.628200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.575000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.706100E-02
Normal-vs-Daily Drinker
1.867860E-02
Normal-vs-Weekly Drinker
3.005200E-01
Normal-vs-Occasional Drinker
1.054990E-01
Normal-vs-Social Drinker
3.281600E-01
Non Drinker-vs-Daily Drinker
3.546400E-01
Non Drinker-vs-Weekly Drinker
7.299600E-01
Non Drinker-vs-Occasional Drinker
4.441800E-01
Non Drinker-vs-Social Drinker
9.902500E-02
Daily Drinker-vs-Weekly Drinker
6.348000E-01
Daily Drinker-vs-Occasional Drinker
1.427370E-01
Daily Drinker-vs-Social Drinker
3.371600E-02
Weekly Drinker-vs-Occasional Drinker
3.384200E-01
Weekly Drinker-vs-Social Drinker
1.062640E-01
Occasional Drinker-vs-Social Drinker
3.976000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.639050E-01
Normal-vs-Grade 2
9.576200E-02
Normal-vs-Grade 3
1.077820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.095200E-01
Grade 1-vs-Grade 3
8.796200E-01
Grade 1-vs-Grade 4
1.639050E-01
Grade 2-vs-Grade 3
7.254200E-01
Grade 2-vs-Grade 4
9.576200E-02
Grade 3-vs-Grade 4
1.077820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.043900E-02
Normal-vs-NonDiabetic
2.168400E-02
Diabetic-vs-NonDiabetic
7.594800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.044580E-01
Normal-vs-NoPancreatitis
2.200400E-02
Pancreatitis-vs-NoPancreatitis
9.507000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.548300E-02
Normal-vs-N1
4.586100E-02
N0-vs-N1
8.415800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.057200E-01
Normal-vs-TP53-NonMutant
2.991000E-01
TP53-Mutant-vs-TP53-NonMutant
6.468400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
